184 related articles for article (PubMed ID: 3110608)
1. 32P-analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anticancer antibiotic, mitomycin C.
Reddy MV; Randerath K
Mutat Res; 1987 Jul; 179(1):75-88. PubMed ID: 3110608
[TBL] [Abstract][Full Text] [Related]
2. Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysis.
Kato S; Yamashita K; Kim T; Tajiri T; Onda M; Sato S
Mutat Res; 1988 Nov; 202(1):85-91. PubMed ID: 2847037
[TBL] [Abstract][Full Text] [Related]
3. Detection of mitomycin C-DNA adducts in vivo by 32P-postlabeling: time course for formation and removal of adducts and biochemical modulation.
Warren AJ; Maccubbin AE; Hamilton JW
Cancer Res; 1998 Feb; 58(3):453-61. PubMed ID: 9458089
[TBL] [Abstract][Full Text] [Related]
4. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
Reddy MV; Randerath K
Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
[TBL] [Abstract][Full Text] [Related]
5. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys.
Snyderwine EG; Davis CD; Nouso K; Roller PP; Schut HA
Carcinogenesis; 1993 Jul; 14(7):1389-95. PubMed ID: 8330355
[TBL] [Abstract][Full Text] [Related]
6. DNA adduct levels of 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) in tissues of cynomolgus monkeys after single or multiple dosing.
Snyderwine EG; Schut HA; Sugimura T; Nagao M; Adamson RH
Carcinogenesis; 1994 Dec; 15(12):2757-61. PubMed ID: 8001231
[TBL] [Abstract][Full Text] [Related]
7. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
Booth ED; Kilgour JD; Robinson SA; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
[TBL] [Abstract][Full Text] [Related]
8. Effect of pH on DNA alkylation by enzyme-activated mitomycin C and porfiromycin.
Yu F; Pan SS
Mol Pharmacol; 1993 Jun; 43(6):863-9. PubMed ID: 8391116
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
[TBL] [Abstract][Full Text] [Related]
10. Detection of mitomycin C-DNA adducts in human breast cancer cells grown in culture, as xenografted tumors in nude mice, and in biopsies of human breast cancer patient tumors as determined by (32)P-postlabeling.
Warren AJ; Mustra DJ; Hamilton JW
Clin Cancer Res; 2001 Apr; 7(4):1033-42. PubMed ID: 11309355
[TBL] [Abstract][Full Text] [Related]
11. DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling.
Stiborová M; Breuer A; Aimová D; Stiborová-Rupertová M; Wiessler M; Frei E
Int J Cancer; 2003 Dec; 107(6):885-90. PubMed ID: 14601046
[TBL] [Abstract][Full Text] [Related]
12. Development of methods for measuring biological markers of formaldehyde exposure.
Fennell TR
Res Rep Health Eff Inst; 1994 Jun; (67):1-20; discussion 21-6. PubMed ID: 7917119
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
14. Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients.
Poirier MC; Reed E; Litterst CL; Katz D; Gupta-Burt S
Cancer Res; 1992 Jan; 52(1):149-53. PubMed ID: 1727376
[TBL] [Abstract][Full Text] [Related]
15. 32P-postlabelling of propylene oxide 1- and N(6)-substituted adenine and 3-substituted cytosine/uracil: formation and persistence in vitro and in vivo.
Plna K; Nilsson R; Koskinen M; Segerbäck D
Carcinogenesis; 1999 Oct; 20(10):2025-32. PubMed ID: 10506120
[TBL] [Abstract][Full Text] [Related]
16. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis.
Reddy MV; Irvin TR; Randerath K
Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues.
Kaderlik KR; Minchin RF; Mulder GJ; Ilett KF; Daugaard-Jenson M; Teitel CH; Kadlubar FF
Carcinogenesis; 1994 Aug; 15(8):1703-9. PubMed ID: 8055652
[TBL] [Abstract][Full Text] [Related]
18. DNA adduct formation by the environmental contaminant 3-nitrobenzanthrone after intratracheal instillation in rats.
Bieler CA; Cornelius MG; Klein R; Arlt VM; Wiessler M; Phillips DH; Schmeiser HH
Int J Cancer; 2005 Oct; 116(6):833-8. PubMed ID: 15856450
[TBL] [Abstract][Full Text] [Related]
19. Monophosphate 32P-postlabeling assay of DNA adducts from 1,2:3,4-diepoxybutane, the most genotoxic metabolite of 1,3-butadiene: in vitro methodological studies and in vivo dosimetry.
Mabon N; Moorthy B; Randerath E; Randerath K
Mutat Res; 1996 Nov; 371(1-2):87-104. PubMed ID: 8950354
[TBL] [Abstract][Full Text] [Related]
20. Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C.
Palom Y; Belcourt MF; Kumar GS; Arai H; Kasai M; Sartorelli AC; Rockwell S; Tomasz M
Oncol Res; 1998; 10(10):509-21. PubMed ID: 10338154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
